Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VUTRISIRAN for Amyloidosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 22 adverse event reports in the FDA FAERS database where VUTRISIRAN was used for Amyloidosis.

Most Reported Side Effects for VUTRISIRAN

Side Effect Reports % Deaths Hosp.
Death 244 17.1% 244 18
Hospitalisation 143 10.0% 6 143
Intentional dose omission 80 5.6% 5 68
Therapy interrupted 66 4.6% 2 46
Fall 65 4.6% 7 38
Fatigue 56 3.9% 0 14
Product dose omission issue 45 3.2% 11 25
Pain in extremity 43 3.0% 0 9
Dyspnoea 42 3.0% 2 20
Gait disturbance 42 3.0% 1 15
Asthenia 37 2.6% 1 22
Arthralgia 36 2.5% 0 12
Cardiac failure 35 2.5% 12 18
Dizziness 34 2.4% 0 13
Neuropathy peripheral 34 2.4% 0 2

Other Indications for VUTRISIRAN

Hereditary neuropathic amyloidosis (965) Product used for unknown indication (324) Acquired attr amyloidosis (60) Cardiac amyloidosis (34) Familial amyloidosis (6)

Other Drugs Used for Amyloidosis

TAFAMIDIS (2,264) LENALIDOMIDE (1,315) BORTEZOMIB (1,044) DEXAMETHASONE (932) TAFAMIDIS MEGLUMINE (641) CYCLOPHOSPHAMIDE (585) POMALIDOMIDE (477) DARATUMUMAB (417) IXAZOMIB (168) MELPHALAN (145)

Related Pages

VUTRISIRAN Full Profile All Amyloidosis Drugs VUTRISIRAN Demographics VUTRISIRAN Timeline